Trying to continue. Gleason was 4+3=7. PSA 4.0 at diagnosis. Primary treatment was RARP. PATHOLOGY AHOWED POSITIVE...

Prostate CancerNovember 12, 2025Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Thank you for those important details. This helps me understand your situation much better.

Your Diagnosis Summary:

  • Gleason 4+3=7 (intermediate-risk prostate cancer)
  • PSA 4.0 at diagnosis
  • Treatment: RARP (Robot-Assisted Radical Prostatectomy)
  • Pathology finding: Positive surgical margins on the left side

This is significant information. Let me explain what this means and what typically happens next:


What Positive Margins Mean

Positive margins mean cancer cells were found at the edge of the tissue removed during surgery. This suggests some cancer may have been left behind, which is why post-operative monitoring and sometimes additional treatment are important.


What Should Have Happened After Surgery

According to the NCCN Guidelines for Prostate Cancer, after RARP with positive margins and Gleason 7 disease, your care team should have:

  1. Monitored your PSA closely (every 3 months initially, then every 6 months)
  2. Considered adjuvant radiation therapy (additional radiation to the prostate bed) to reduce recurrence risk
  3. Possibly recommended hormone therapy depending on other risk factors

My key questions for you:

  1. After your 2007 surgery, did you receive any additional treatment? (radiation therapy or hormone therapy?)
  2. What has your PSA been doing over these 17 years? Has it remained undetectable, or has it risen?
  3. Are you currently under active surveillance, or have you lost follow-up?

This context will help me guide you toward the most relevant current information and recommendations.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: